AB Science provides an update on the application for conditional marketing authorisation of masitinib in ALS

Barchart · 10/17 12:29

PRESS RELEASE

AB SCIENCE PROVIDES AN UPDATE ON THE APPLICATION FOR CONDITIONAL MARKETING AUTHORISATION OF MASITINIB IN THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS

Read more at globenewswire.com